CVC Credit led an incremental $57 million multicurrency first lien credit facility for Calibre Scientific.
Headquartered in Los Angeles, Calibre Scientific is a diversified global developer, manufacturer and distributor of consumable products in the life science tools and diagnostics markets.
CVC Credit originally provided a $92 million multicurrency first lien credit facility for Calibre Scientific in June 2020, and since then the company has completed five add-on acquisitions.
“We are happy to have secured further financing to support our ongoing acquisition growth strategy. We have significantly expanded our geographic footprint over the past six months and intend to continue this rapid rate of growth by completing further acquisitions from our full pipeline of opportunities,” Dr. Benjamin Travis, CEO of Calibre Scientific, said.
“CVC Credit have been valuable and supportive since they came on board in mid-2020. They have demonstrated responsiveness and efficiency in our partnership and have clearly helped fuel our international growth strategy,” Brian Wall, founder and CEO of StoneCalibre, said.
“Run by a strong management team and augmented with a supportive and engaged sponsor, Calibre Scientific is performing well and successfully executing on its ambitious growth strategy. We are very pleased to have strengthened our commitment to a company delivering high societal impact, particularly at a time when their mission is more important than ever,” Andrew Eversfield, managing director of CVC Credit Partners’ U.S. private debt business, said.
